Business description
The biopharmaceutical company co.don AG based near Berlin is one of the leading specialists worldwide in cell cultivation for the regenerative treatment of articular cartilage defects and spinal disc defects. The company's patented pharmaceutical products are used to treat cartilage damage. Left untreated, cartilage defects can often result in joint replacement surgery.
Management board & Supervisory board
| CEO |
| - |
| Management board |
| Dr. Achim Simons, Tilmann Bur |
| Supervisory board |
| Prof. Hans B. Bauerfeind, Thommy Stählin, Beatrix Bauerfeind-Johnson, Prof. Dr. Barbara Sickmüller, Prof. Dr. Hans-Jörg Bullinger, Thomas Krause |
Company data
| Name: |
Co.don AG |
| Address: |
Warthestraße 21,D-14513 Teltow |
| Phone: |
+49-3328-4346-0 |
| Fax: |
+49-3328-4346-43 |
| E-mail: |
info@codon.de
|
| Internet: |
www.codon.de |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
12-31 |
| Free Float: |
41.56% |
| IPO date: |
2001-02-14 |
Investor relations
| Name: |
Matthias Meißner |
| IR phone: |
49-30-2403-52-330 |
| IR Fax: |
- |
| IR e-mail: |
ir@codon.de
|
